| Gleason score and lethal prostate cancer: does 3+ 4= 4+ 3? JR Stark, S Perner, MJ Stampfer, JA Sinnott, S Finn, AS Eisenstein, J Ma, ... Journal of Clinical Oncology 27 (21), 3459-3464, 2009 | 457 | 2009 |
| mRNA expression signature of Gleason grade predicts lethal prostate cancer KL Penney, JA Sinnott, K Fall, Y Pawitan, Y Hoshida, P Kraft, JR Stark, ... Journal of Clinical Oncology 29 (17), 2391-2396, 2011 | 166 | 2011 |
| Ejaculation frequency and risk of prostate cancer: updated results with an additional decade of follow-up JR Rider, KM Wilson, JA Sinnott, RS Kelly, LA Mucci, EL Giovannucci European urology 70 (6), 974-982, 2016 | 165 | 2016 |
| Association of Prostate Cancer Risk Variants with Gene Expression in Normal and Tumor Tissue KL Penney, JA Sinnott, S Tyekucheva, T Gerke, IM Shui, P Kraft, ... Cancer Epidemiology Biomarkers & Prevention 24 (1), 255-260, 2015 | 150 | 2015 |
| Gleason Grade Progression Is Uncommon KL Penney, MJ Stampfer, JL Jahn, JA Sinnott, R Flavin, JR Rider, S Finn, ... Cancer research 73 (16), 5163-5168, 2013 | 92 | 2013 |
| SPINK1 protein expression and prostate cancer progression R Flavin, A Pettersson, WK Hendrickson, M Fiorentino, S Finn, L Kunz, ... Clinical Cancer Research 20 (18), 4904-4911, 2014 | 83 | 2014 |
| Life after endometrial cancer: A systematic review of patient-reported outcomes R Shisler, JA Sinnott, V Wang, C Hebert, R Salani, AS Felix Gynecologic oncology 148 (2), 403-413, 2018 | 75 | 2018 |
| Cholesterol metabolism and prostate cancer lethality KH Stopsack, TA Gerke, JA Sinnott, KL Penney, S Tyekucheva, HD Sesso, ... Cancer Research 76 (16), 4785-4790, 2016 | 70 | 2016 |
| Prognostic utility of a new mRNA expression signature of Gleason score JA Sinnott, SF Peisch, S Tyekucheva, T Gerke, R Lis, JR Rider, ... Clinical Cancer Research 23 (1), 81-87, 2017 | 67 | 2017 |
| Genome-wide association study of prostate cancer mortality KL Penney, S Pyne, FR Schumacher, JA Sinnott, LA Mucci, PL Kraft, J Ma, ... Cancer Epidemiology Biomarkers & Prevention 19 (11), 2869-2876, 2010 | 65 | 2010 |
| Protein expression of PTEN, insulin-like growth factor I receptor (IGF-IR), and lethal prostate cancer: a prospective study K Zu, NE Martin, M Fiorentino, R Flavin, RT Lis, JA Sinnott, S Finn, ... Cancer Epidemiology Biomarkers & Prevention 22 (11), 1984-1993, 2013 | 54 | 2013 |
| Molecular differences in transition zone and peripheral zone prostate tumors JA Sinnott, JR Rider, J Carlsson, T Gerke, S Tyekucheva, KL Penney, ... Carcinogenesis 36 (6), 632-638, 2015 | 53 | 2015 |
| Effect of dietary polyunsaturated fatty acids on castration-resistant Pten-null prostate cancer S Wang, J Wu, J Suburu, Z Gu, J Cai, LS Axanova, SD Cramer, ... Carcinogenesis 33 (2), 404-412, 2012 | 51 | 2012 |
| Expression of IGF/insulin receptor in prostate cancer tissue and progression to lethal disease TU Ahearn, S Peisch, A Pettersson, EM Ebot, CK Zhou, RE Graff, ... Carcinogenesis 39 (12), 1431-1437, 2018 | 47 | 2018 |
| Improving the power of genetic association tests with imperfect phenotype derived from electronic medical records JA Sinnott, W Dai, KP Liao, SY Shaw, AN Ananthakrishnan, VS Gainer, ... Human genetics 133, 1369-1382, 2014 | 45 | 2014 |
| Toll-like receptor signaling pathway variants and prostate cancer mortality JR Stark, F Wiklund, H Grönberg, F Schumacher, JA Sinnott, MJ Stampfer, ... Cancer Epidemiology Biomarkers & Prevention 18 (6), 1859-1863, 2009 | 41 | 2009 |
| Artifact due to differential error when cases and controls are imputed from different platforms JA Sinnott, P Kraft Human genetics 131, 111-119, 2012 | 39 | 2012 |
| The role of tumor metabolism as a driver of prostate cancer progression and lethal disease: results from a nested case-control study RS Kelly, JA Sinnott, JR Rider, EM Ebot, T Gerke, M Bowden, ... Cancer & metabolism 4, 1-9, 2016 | 33 | 2016 |
| Immunohistochemical expression of BRCA1 and lethal prostate cancer M Fiorentino, G Judson, K Penney, R Flavin, J Stark, C Fiore, K Fall, ... Cancer research 70 (8), 3136-3139, 2010 | 33 | 2010 |
| Tumor expression of adiponectin receptor 2 and lethal prostate cancer JR Rider, M Fiorentino, R Kelly, T Gerke, K Jordahl, JA Sinnott, ... Carcinogenesis 36 (6), 639-647, 2015 | 31 | 2015 |
